BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 9045913)

  • 1. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens.
    Pion S; Fontaine P; Desaulniers M; Jutras J; Filep JG; Perreault C
    Eur J Immunol; 1997 Feb; 27(2):421-30. PubMed ID: 9045913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-strain graft-vs.-host disease T-cell responses to immunodominant minor histocompatibility antigens.
    Korngold R; Leighton C; Mobraaten LE; Berger MA
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):57-64. PubMed ID: 9267665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes.
    Wolpert EZ; Grufman P; Sandberg JK; Tegnesjö A; Kärre K
    J Immunol; 1998 Nov; 161(9):4499-505. PubMed ID: 9794374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an immunodominant mouse minor histocompatibility antigen (MiHA). T cell response to a single dominant MiHA causes graft-versus-host disease.
    Perreault C; Jutras J; Roy DC; Filep JG; Brochu S
    J Clin Invest; 1996 Aug; 98(3):622-8. PubMed ID: 8698852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
    Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
    J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of cytotoxic T cells specific for minor histocompatibility antigens by cross challenge in vitro with H-2 disparate adherent cells.
    Pilarski LM; Carayanniotis G
    J Immunol; 1985 Dec; 135(6):3686-90. PubMed ID: 2415580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation with dendritic cells decreases or obviates the CD4+ helper cell requirement in cytotoxic T lymphocyte responses.
    Boog CJ; Boes J; Melief CJ
    Eur J Immunol; 1988 Feb; 18(2):219-23. PubMed ID: 2965021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunodominant CD4+ T cell receptor Vbeta repertoires involved in graft-versus-host disease responses to minor histocompatibility antigens.
    Berger MA; Korngold R
    J Immunol; 1997 Jul; 159(1):77-85. PubMed ID: 9200441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential binding of a minor histocompatibility antigen peptide to H-2 class I molecules correlates with immune responsiveness.
    Wettstein PJ; van Bleek GM; Nathenson SG
    J Immunol; 1993 Apr; 150(7):2753-60. PubMed ID: 7681080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helper effects required during in vivo priming for a cytolytic response to the H-Y antigen in nonresponder mice.
    Juretić A; Malenica B; Juretić E; Klein J; Nagy ZA
    J Immunol; 1985 Mar; 134(3):1408-14. PubMed ID: 2578505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular and functional characterization of a dominant minor H antigen, H60.
    Malarkannan S; Shih PP; Eden PA; Horng T; Zuberi AR; Christianson G; Roopenian D; Shastri N
    J Immunol; 1998 Oct; 161(7):3501-9. PubMed ID: 9759870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonresponsiveness to the male antigen H-Y in H-2 I-A-mutant B6.C-H-2bm12 is not caused by defective antigen presentation.
    de Waal LP; de Hoop J; Stukart MJ; Gleichmann H; Melvold RW; Melief CJ
    J Immunol; 1983 Feb; 130(2):655-60. PubMed ID: 6401303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodominance in the T cell response to multiple non-H-2 histocompatibility antigens. III. Single histocompatibility antigens dominate the male antigen.
    Wettstein PJ
    J Immunol; 1986 Oct; 137(7):2073-9. PubMed ID: 3489751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The target minor H antigen for F1 cytotoxic T lymphocytes induced by Igh-congenic parental spleen cells is coded for by gene linked to H-2.
    Ishikawa H; Kubota E; Suzuki H; Saito K
    J Immunol; 1985 May; 134(5):2953-9. PubMed ID: 2580009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance to host minor histocompatibility antigens after allogenic bone marrow transplantation. Specific donor-host unresponsiveness is maintained by peripheral tolerizing cells.
    Brochu S; Roy DC; Perreault C
    J Immunol; 1992 Nov; 149(10):3135-41. PubMed ID: 1431092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T lymphocyte responses to minor H-43 alloantigens in H-43a and H-43b mice. Both anti-H-43b and anti-H-43a CTL activities are generated exclusively in the context of the same H-2Kb restriction element.
    Ishikawa H; Kusakabe A; Hayakawa J; Hino T
    J Immunol; 1988 Nov; 141(9):2918-23. PubMed ID: 3139769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hapten epitope structure and hapten-self conjugation pattern on T cell specificity and Ir gene control in hapten-self cytotoxic and helper T cell responses.
    Takai Y; Mizuochi T; Fujiwara H; Hamaoka T
    J Immunol; 1984 Jan; 132(1):57-62. PubMed ID: 6197460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vivo fate of APCs displaying minor H antigen and/or MHC differences is regulated by CTLs specific for immunodominant class I-associated epitopes.
    Loyer V; Fontaine P; Pion S; Hétu F; Roy DC; Perreault C
    J Immunol; 1999 Dec; 163(12):6462-7. PubMed ID: 10586037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.